These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Topical delta 9-tetrahydrocannabinol and aqueous dynamics in glaucoma. Merritt JC; Perry DD; Russell DN; Jones BF J Clin Pharmacol; 1981; 21(S1):467S-471S. PubMed ID: 6271841 [TBL] [Abstract][Full Text] [Related]
3. [Action of delta-9-tetrahydrocannabinol on ophthalmotonus]. Cuendet JF; Shapiro D; Calanca A; Faggioni R; Ducrey N Ophthalmologica; 1976; 172(2-3):122-7. PubMed ID: 1256748 [No Abstract] [Full Text] [Related]
4. Cannabinoids in glaucoma II: the effect of different cannabinoids on intraocular pressure of the rabbit. ElSohly MA; Harland EC; Benigni DA; Waller CW Curr Eye Res; 1984 Jun; 3(6):841-50. PubMed ID: 6329602 [TBL] [Abstract][Full Text] [Related]
5. Effect of delta-9-tetrahydrocannabinol on intraocular pressure in humans. Cooler P; Gregg JM South Med J; 1977 Aug; 70(8):951-4. PubMed ID: 329423 [TBL] [Abstract][Full Text] [Related]
6. A comparison of the effects of oral nadolol and topical timolol on intraocular pressure, blood pressure, and heart rate. Duff GR; Watt AH; Graham PA Br J Ophthalmol; 1987 Sep; 71(9):698-700. PubMed ID: 3663564 [TBL] [Abstract][Full Text] [Related]
7. Multiple-drop study of topically applied 1% delta 9-tetrahydrocannabinol in human eyes. Jay WM; Green K Arch Ophthalmol; 1983 Apr; 101(4):591-3. PubMed ID: 6301412 [TBL] [Abstract][Full Text] [Related]
8. [CANNABIS AND GLAUCOMA: AN ANCIENT LEGEND OR A NOVEL THERAPEUTIC HORIZON?]. Mathalone N; Wolf A; Geyer O Harefuah; 2015 Jun; 154(6):394-7, 403. PubMed ID: 26281086 [TBL] [Abstract][Full Text] [Related]
12. Effects of tetrahydrocannabinol on arterial and intraocular hypertension. Crawford WJ; Merritt JC Int J Clin Pharmacol Biopharm; 1979 May; 17(5):191-6. PubMed ID: 468444 [TBL] [Abstract][Full Text] [Related]
13. Tolerance of delta-9-tetrahydrocannabinol in the spontaneously hypertensive rat. Nahas GG; Schwartz IW; Adamec J; Manger WM Proc Soc Exp Biol Med; 1973 Jan; 142(1):58-60. PubMed ID: 4683264 [No Abstract] [Full Text] [Related]
14. The effects of delta-9-tetrahydrocannabinol (cannabis) on cardiac performance with and without beta blockade. Kanakis C; Pouget JM; Rosen KM Circulation; 1976 Apr; 53(4):703-7. PubMed ID: 1253395 [TBL] [Abstract][Full Text] [Related]
15. Lack of tolerance to the bradycardic effect of delta 9-trans-tetrahydrocannabinol in rats. Kaymakçalan S; Sivil S Pharmacology; 1974; 12(4-5):290-5. PubMed ID: 4449891 [No Abstract] [Full Text] [Related]
16. Ocular effects of topical administration of delta 9-tetrahydrocannabinol in man. Green K; Roth M Arch Ophthalmol; 1982 Feb; 100(2):265-7. PubMed ID: 6279061 [TBL] [Abstract][Full Text] [Related]
17. High interest in medical uses of marijuana and synthetic analogues [new]. Montgomery BJ JAMA; 1978 Sep; 240(14):1469-70. PubMed ID: 682339 [No Abstract] [Full Text] [Related]
18. A randomised controlled trial of vaporised Δ Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105 [TBL] [Abstract][Full Text] [Related]